E. Bellur, P. Langer
FULL PAPER
2.7 Hz, 2 H, OCH2CH3), 4.39–4.54 (m, 2 H, OCH2), 5.81 (m, 1 H, 3,3-Dibromo-4,4Ј,5,5Ј-tetrahydro-2,3Ј-bifuranyliden-2Ј-one (6h): 1H
CH–Br) ppm. 13C NMR (CDCl3, 75 MHz): δ = 11.6, 14.3, 36.7, NMR (CDCl3, 300 MHz): δ = 3.26 (t, J = 6.5 Hz, 2 H, CH2), 3.33
45.1, 60.1, 69.1, 100.4, 167.1, 167.6 ppm. IR (neat): ν = 2984 (m),
2930 (w), 2904 (w), 1699 (s), 1644 (s), 1469 (w), 1441 (m), 1390 (w),
(t, J = 7.5 Hz, 2 H, CH2), 4.40 (t, J = 7.5 Hz, 2 H, OCH2), 4.49 (t,
J = 6.5 Hz, 2 H, OCH2) ppm. 13C NMR (CDCl3, 150 MHz): δ =
˜
1369 (m), 1288 (s), 1212 (m), 1185 (m), 1170 (m), 1107 (s), 1082 26.2, 50.3, 51.0, 65.7, 70.5, 98.2, 163.0, 170.3 ppm. IR (KBr): ν =
˜
(s), 1024 (m), 972 (w), 933 (w), 880 (w), 767 (w), 704 (w) cm–1. MS 2908 (w), 1738 (s), 1663 (s), 1224 (w), 1197 (w), 1149 (s), 1134 (m),
(EI, 70 eV): m/z (%) = 250 ([81Br], 29) [M]+, 248 ([79Br], 34) [M]+, 1070 (w), 1029 (m), 991 (w), 728 (w) cm–1. MS (EI, 70 eV): m/z (%)
205 (14), 203 (16), 169 (83), 141 (100), 123 (54), 99 (3), 97 (3), 95
(32), 83 (49), 68 (33). HRMS (ESI): calcd. for C9H13BrO3 [M]+:
250.00276 (81Br), 248.00481 (79Br); found 250.00210 (81Br),
= 314 ([2×81Br], 2) [M+], 312 ([81Br 79Br], 6) [M]+, 310 ([2×79Br],
3) [M]+, 234 (10), 233 (29), 232 (14), 231 (33), 189 (96), 188 (56),
187 (100), 186 (29), 185 (8), 184 (8), 180 (6), 178 (7), 177 (12), 175
248.00485 (79Br). C9H13BrO3 (249.104): calcd. C 43.40, H 5.26; (20), 173 (6), 153 (14), 150 (13), 148 (9), 123 (7), 121 (5), 112 (5),
found C 42.74, H 4.87.
107 (12), 95 (14), 81 (10), 79 (15), 77 (10), 68 (13), 66 (16). The
exact molecular mass, m/z = 309.8840 2 ppm [M]+, for C8H8BrO3
was confirmed by HRMS (EI, 70 eV).
Ethyl
2-[3,3-Dibromo-4,5-dihydrofuran-2(3H)-ylidene]propionate
(6f): 1H NMR (CDCl3, 300 MHz): δ = 1.31 (t, J = 7.2 Hz, 3 H,
CH3), 2.21 (s, 3 H, CH3), 3.27 (t, J = 6.3 Hz, 2 H, CH2), 4.22 (q,
J = 7.2 Hz, 2 H, OCH2CH3), 4.32 (t, J = 6.3 Hz, 2 H, OCH2) ppm.
13C NMR (CDCl3, 75 MHz): δ = 14.2, 14.6, 50.4, 51.7, 60.5, 68.7,
Ethyl
2-Bromo-2-[3-bromo-5-vinyl-4,5-dihydrofuran-2(3H)-ylid-
ene]acetate (4i): Starting with 2i (1.500 g, 8.23 mmol) and NBS
(2.344 g, 13.17 mmol) in CCl4 (30 mL), Z-4i (1.392 g, 50%) and E-
4i (0.736 g, 26%) were isolated, each as a 10:1 mixture of cis/trans
diastereomers, after chromatography (silica gel, n-hexane/EtOAc =
100:1 Ǟ 1:1) as a colorless solid and a yellowish oil (combined
yield: 76%), respectively.
103.2, 162.1, 167.2 ppm. IR (neat): ν = 2981 (w), 2931 (w), 2902
˜
(w), 1713 (s), 1636 (m), 1443 (w), 1371 (w), 1318 (w), 1290 (m),
1279 (m), 1204 (m), 1174 (m), 1141 (s), 1103 (s), 1030 (w), 1001
(w), 738 (w) cm–1. MS (EI, 70 eV): m/z (%) = 328 ([81Br 79Br], 11)
[M]+, 326 ([2×79Br], 2) [M]+, 285 (4), 283 (16), 281 (4), 249 (54),
247 (54), 221 (59), 219 (56), 205 (3), 204 (10), 203 (12), 202 (10),
201 (6), 177 (2), 175 (14), 173 (5), 169 (21), 167 (7), 165 (6), 141
(28), 139 (77), 129 (16), 123 (16), 108 (3), 95 (18), 83 (100), 66 (54).
HRMS (ESI): calcd. for C9H12Br2O3 [M]+: 329.91127 (2×81Br),
327.91327 (81Br79Br), 325.91532 (2×79Br); found 329.90904
(2×81Br), 327.91240 (81Br79Br), 325.91549 (2×79Br).
Compound Z-4i: 1H NMR (CDCl3, 300 MHz): major diastereomer:
δ = 1.36 (t, J = 7.2 Hz, 3 H, CH3), 2.30–2.40 (m, 1 H, CH2), 2.67
(dd, J = 14.4, 4.5 Hz, 1 H, CH2), 4.29 (dq, J = 7.2, 2.4 Hz, 2 H,
OCH2), 5.29–5.35 (m, 1 H, CH), 5.38 (dt, J = 10.5, 0.9 Hz, 1 H,
CH2=CH), 5.53 (dt, J = 17.1, 1.2 Hz, 1 H, CH2=CH), 5.83 (d, J =
5.4 Hz, 1 H, CH–Br), 5.89–6.00 (m, 1 H, CH=CH2) ppm; minor
diastereomer: δ = 1.29 (t, J = 7.2 Hz, 3 H, CH3), 2.19–2.28 (m, 1
H, CH2), 2.58 (dd, J = 15.0, 4.5 Hz, 1 H, CH2), 4.18 (dq, J = 7.2,
2.1 Hz, 2 H, OCH2), 5.14–5.24 (m, 1 H, CH), 5.31–5.35 (d, 1 H,
CH2=CH), 5.40–5.42 (d, 1 H, CH2=CH), 5.80 (d, J = 5.4 Hz, 1 H,
CH–Br), 5.81–5.88 (m, 1 H, CH=CH2) ppm. 13C NMR (CDCl3,
75 MHz): major diastereomer: δ = 14.2, 43.1, 44.5, 61.9, 83.6, 87.4,
120.1, 133.6, 162.9, 168.2 ppm; minor diastereomer: δ = 14.3, 42.1,
Ethyl 2-[3-Bromo-4,5-dihydrofuran-2(3H)-ylidene]butyrate (5g):
Starting with 2-[4,5-dihydro-furan-2(3H)-ylidene]butyric acid ethyl
ester (2g) (1.000 g, 5.43 mmol) and NBS (1.063 g, 5.97 mmol) in
CCl4 (30 mL), 5g was isolated after chromatography (silica gel, n-
hexane/EtOAc = 100:1 Ǟ 1:1) as a yellowish oil (1.140 g, 80%). 1H
NMR (CDCl3, 300 MHz): δ = 0.99 (t, J = 7.4 Hz, 3 H, CH3), 1.32
(t, J = 7.2 Hz, 3 H, CH3), 2.29–2.38 (m, 2 H, CH2), 2.42–2.49 (m,
2 H, CH2), 4.18–4.27 (m, 2 H, OCH2CH3), 4.41–4.50 (m, 2 H,
OCH2), 5.81 (m, 1 H, CH–Br) ppm. 13C NMR (CDCl3, 75 MHz):
δ = 12.7, 13.9, 19.2, 36.3, 45.1, 59.6, 68.8, 106.3, 166.8, 166.9 ppm.
43.4, 59.8, 82.5, 87.4, 119.7, 134.2, 162.9, 166.8 ppm. IR (KBr): ν
˜
= 2983 (w), 1698 (s), 1651 (w), 1614 (s), 1445 (w), 1369 (w), 1323
(w), 1277 (s), 1234 (w), 1215 (s), 1186 (m), 1120 (m), 1067 (s), 992
(m), 958 (m), 939 (m), 927 (m), 864 (m), 847 (m), 756 (w) cm–1.
MS (EI, 70 eV): m/z (%) = 342 ([2×81Br], 32) [M]+, 340 ([81Br 79Br],
69) [M]+, 338 ([2×79Br], 34) [M]+, 297 (7), 295 (12), 293 (6), 261
(29), 259 (74), 233 (45), 231 (50), 215 (100), 213 (100), 195 (25),
193 (27), 187 (28), 185 (26), 167 (28), 165 (29), 159 (17), 157 (16),
148 (23), 146 (29), 135 (9), 134 (15), 133 (14), 108 (10), 107 (17),
106 (21), 105 (9), 95 (11), 79 (52). The exact molecular mass, m/z
= 337.9153 2 ppm [M]+, for C10H12Br2O3 was confirmed by
HRMS (EI, 70 eV).
IR (neat): ν = 2975 (s), 2936 (m), 2905 (w), 2877 (w), 1696 (s), 1639
˜
(s), 1448 (m), 1371 (m), 1307 (s), 1253 (s), 1212 (m), 1185 (s), 1105
(s), 1055 (m), 1032 (s), 990 (w), 951 (w), 877 (w), 780 (w) cm–1. MS
(EI, 70 eV): m/z (%) = 264 ([81Br], 21) [M]+, 262 ([79Br], 23) [M]+,
249 (3), 247 (3), 219 (14), 217 (15), 203 (5), 201 (4), 191 (5), 189 (5),
183 (100), 155 (57), 137 (50), 109 (21), 81 (15), 70 (50). C10H15BrO3
(263.131): calcd. C 45.65, H 5.75; found C 45.05, H 5.55.
Compounds 5h and 6h: Starting with tetrahydro-2,3Ј-bifuranyliden-
2Ј-one (2h) (0.200 g, 1.30 mmol) and NBS (0.277 g, 1.56 mmol) in
CCl4 (10 mL), 5h (0.229 g, 76%) and 6h (0.089 g, 22%) were iso-
lated after chromatography (silica gel, n-hexane/EtOAc = 20:1 Ǟ
1:1) as slightly yellowish solids.
Compound E-4i: 1H NMR (CDCl3, 300 MHz): major diastereomer:
δ = 1.31 (t, J = 7.2 Hz, 3 H, CH3), 2.30–2.40 (m, 1 H, CH2), 2.56–
2.62 (dd, J = 4.8, 14.4 Hz, 1 H, CH2), 4.19–4.28 (m, 2 H, OCH2),
5.22 (d, J = 5.7 Hz, 1 H, CH), 5.34–5.46 (m, 2 H, CH2=CH), 5.51
3-Bromo-4,4Ј,5,5Ј-tetrahydro-2,3Ј-bifuranyliden-2Ј-one (5h): 1H (d, J = 17.1 Hz, 1 H, CH), 5.91–6.02 (m, CH=CH2) ppm. 13C
NMR (CDCl3, 300 MHz): δ = 2.46–2.52 (m, 2 H, CH2), 2.75–3.02 NMR (CDCl3, 75 MHz): major diastereomer: δ = 14.0, 41.2, 48.7,
(m, 2 H, CH2), 4.31–4.39 (m, 2 H, OCH2), 4.47–4.58 (m, 2 H,
61.5, 86.5, 88.3, 119.3, 133.7, 162.0, 166.2 ppm; minor dia-
OCH2), 5.82–5.84 (m, 1 H, CH–Br) ppm. 13C NMR (CDCl3, stereomer: δ = 14.1, 41.2, 48.7, 61.0, 84.8, 88.3, 117.6, 135.0, 164.0,
150 MHz): δ = 25.0, 36.1, 41.8, 65.3, 70.4, 95.7, 166.3, 171.1 ppm.
171.0 ppm. IR (neat): ν = 2984 (m), 2935 (w), 2907 (w), 1705 (s),
˜
IR (KBr): ν = 2910 (w), 1737 (s), 1683 (s), 1366 (m), 1254 (s), 1222
1653 (m), 1616 (s), 1461 (w), 1430 (m), 1392 (w), 1369 (m), 1330
(s), 1299 (s), 1269 (s), 1194 (s), 1097 (m), 1056 (s), 1011 (s), 991 (s),
˜
(m), 1184 (m), 1166 (m), 1080 (m), 1051 (s), 1029 (s), 993 (w), 931
(w), 670 (w) cm–1. MS (EI, 70 eV): m/z (%) = 234 ([81Br], 92) [M] 962 (m), 940 (s), 863 (w), 846 (w), 763 (m), 696 (w) cm–1. MS (EI,
+, 232 ([79Br], 86) [M]+, 153 (100), 125 (14), 123 (20), 107 (32), 97
(23), 95 (39), 85 (14), 81 (23), 79 (34), 70 (35), 68 (40). The exact
molecular mass, m/z = 231.9735 2 ppm [M]+, for C8H9BrO3 was
confirmed by HRMS (EI, 70 eV).
70 eV): m/z (%) = 342 ([2×81Br], 18) [M]+, 340 ([81Br 79Br], 52) [M]
+, 338 ([2×79Br], 19) [M]+, 297 (9), 295 (24), 293 (8), 262 (11), 261
(44), 260 (12), 259 (31), 233 (26), 231 (28), 215 (100), 213 (69), 195
(23), 193 (28), 189 (11), 187 (34), 185 (22), 173 (9), 171 (11), 167
4822
© 2005 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Org. Chem. 2005, 4815–4828